CS logo
small CS logo
Nalitt Cancer Institute at Staten Island University Hospital

Staten Island, New York, United States
Cancer treatment center in Staten Island, New York
1 C, 256 Mason Ave, Staten Island, NY 10305

About Nalitt Cancer Institute at Staten Island University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Nalitt Cancer Institute at Staten Island University Hospital


During the past decade, Nalitt Cancer Institute at Staten Island University Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 12 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Serotonin Effect in Functional Dyspepsia
2005-07-01
2007-07-01
Completed
300
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
2005-10-01
2009-05-01
Unknown status
5,200
Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals
2002-09-01
2005-04-01
Completed
2,000
Efficiency of Physiotherapeutic Care in Parkinson's Disease
2006-05-01
2007-07-01
Completed
708
Cost-effectiveness of TPMT Pharmacogenetics
2007-09-01
2011-12-01
Completed
853
Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease
2008-09-01
2011-12-01
Completed
700
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
2009-04-01
2014-02-01
Completed
987

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Nalitt Cancer Institute at Staten Island University Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 6 trials, followed by "NSABP Foundation Inc" with 5 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nalitt Cancer Institute at Staten Island University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Nalitt Cancer Institute at Staten Island University Hospital


According to Clinical.Site data, the most researched conditions in "Nalitt Cancer Institute at Staten Island University Hospital" are "Breast Cancer" (7 trials), "Colorectal Cancer" (3 trials), "Metastatic Cancer" (2 trials), "Pain" (2 trials) and "Breast Adenocarcinoma" (1 trials). Many other conditions were trialed in "Nalitt Cancer Institute at Staten Island University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Nalitt Cancer Institute at Staten Island University Hospital


Most popular intervention types in "Nalitt Cancer Institute at Staten Island University Hospital" are "Drug" (13 trials), "Other" (6 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (4 trials), "bevacizumab" (2 trials), "cyclophosphamide" (2 trials), "radiation therapy" (2 trials) and "zoledronic acid" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Nalitt Cancer Institute at Staten Island University Hospital


The vast majority of trials in "Nalitt Cancer Institute at Staten Island University Hospital" are 9 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Nalitt Cancer Institute at Staten Island University Hospital


Currently, there are NaN active trials in "Nalitt Cancer Institute at Staten Island University Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Nalitt Cancer Institute at Staten Island University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Nalitt Cancer Institute at Staten Island University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status